Navigation Links
Genomic Health Presents Ten New Studies in Breast, Colon and Prostate Cancers at the American Society of Clinical Oncology (ASCO) Annual Meeting
Date:6/4/2011

CHICAGO, June 4, 2011 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced results of ten studies being presented at the American Society of Clinical Oncology (ASCO) Annual Meeting, including a second large validation study confirming the performance of the Oncotype DX® colon cancer Recurrence Score® (RS) as an independent predictor of recurrence risk in stage II colon cancer.  The company also will present positive findings from a prostate gene identification study, as well as multiple studies in breast cancer including one suggesting that neoadjuvant treatment selection can also be guided by the underlying biology revealed by the Oncotype DX breast cancer test.

"Our continued research in breast, colon and prostate cancers add to the growing body of clinical evidence demonstrating the importance of understanding and treating a patient's underlying individual tumor biology," said Steven Shak, M.D., chief medical officer at Genomic Health,  "These ten studies presented at ASCO reflect our ability to continue adding value to the Oncotype DX breast and colon cancer tests that physicians use today, while accelerating our prostate cancer clinical development program, with the goal of making a test for biopsy specimens available to patients and physicians in 2013."

Research Highlights:

Colon Cancer:  

Second Successful Prospectively-Designed Study Confirms Oncotype DX Colon Cancer Test Provides Value Beyond Conventional Markers

Supporting the original QUASAR study presented at ASCO in 2009, new results from a separate large clinical validation study of stage II colon cancer patients enrolled in CALGB 9581 further confirms that the Oncotype DX Recurrence Score result improves the ability to differentiate higher from low
'/>"/>

SOURCE Genomic Health, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Everist Genomics Announces New Data on OncoDefender™- CRC Test for Predicting Recurrence Risk for Stage I and II Colorectal Cancer Patients
2. Genomic Health to Present at Two Upcoming Investor Conferences
3. Signal Genetics Announces Commercialization Partnership with NeoGenomics Laboratories for Multiple Myeloma Gene Expression Test
4. Transgenomic, Inc. Acquires Exclusive Worldwide License to Predictive Markers for Cancer Drug Response
5. Genomic Health Announces Ten Studies Covering Breast, Colon and Prostate Cancers Accepted for Presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting
6. Transgenomic Reports First Quarter Financial Results
7. Reminder: Transgenomic to Hold First Quarter Financial Results Conference Call Today
8. GT Life Sciences Broadens Intellectual Property Portfolio with Issuance of U.S. Patent on Core Computational Systems and Methods for Genomic-based Metabolic Modeling
9. CrystalGenomics Completes Phase I MAD Study of its Novel Antibiotic Candidate CG400549, and Prepares for Phase II Clinical Study
10. Rosetta Genomics Announces Issuance of Additional U.S. Patent
11. Transgenomic, Inc. Presents Its Latest Technology at the BIT Life Sciences World DNA and Genome Day Conference, Dalian, China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... June 24, 2015 ... addition of the "2015 Strategies in the ... This new 175-page report provides analysis ... diabetes (strips and meters), pregnancy, ovulation, and occult ... regulatory requirements, technologies, and competitive profiles. ...
(Date:7/1/2015)... KONG and FT LAUDERDALE, Florida ... Inc. ("OrbusNeich"), a designer, developer, manufacturer and marketer of innovative ... that on May 13, 2015, it prevailed in a final ... European Patent EP 1 341 482 - STENT HAVING HELICAL ... of review in the EPO and has been upheld as ...
(Date:7/1/2015)... , July 1, 2015 Dynatronics ... manufacturer and marketer of rehabilitation and physical therapy ... $4,025,000 private placement financing led by affiliates of ... equity investor focused on the healthcare industry. The ... organic growth and pursue potential strategic acquisitions.  ...
Breaking Medicine Technology:2015 Strategies in the Home/Self Testing Market 2OrbusNeich Announces Favorable Ruling from the European Patent Office and Initiation of Litigation Against Terumo Corporation 2Dynatronics Announces Completion Of $4,025,000 Private Placement Led By Prettybrook Partners 2Dynatronics Announces Completion Of $4,025,000 Private Placement Led By Prettybrook Partners 3
... Corporation (NYSE: CVS ) today announced that ... repurchase program for up to $4.0 billion of the ... is effective immediately, permits the company to effect the ... open market repurchases, privately negotiated transactions, accelerated share repurchase ...
... Inc. (Pink Sheets: GATA ) announced on August 15, ... are currently processing, and they are expecting this number to increase ... company expects to be able to convert at least two thirds ... The company also stated that due to the ...
Cached Medicine Technology:CVS Caremark Corporation Announces New Share Repurchase Authorization for up to $4 Billion of Common Stock 2CVS Caremark Corporation Announces New Share Repurchase Authorization for up to $4 Billion of Common Stock 3Groupe Athena, Inc. Clarifies Previous Guidance 2Groupe Athena, Inc. Clarifies Previous Guidance 3
(Date:7/1/2015)... , ... July 01, 2015 , ... Dr. Surya Challa ... July 6th on WAVY-TV’s The Hampton Roads Show to discuss non-invasive CoolSculpting . ... and exercise fall short. , CoolSculpting fat reduction utilizes Cryolipolysis to literally freeze ...
(Date:7/1/2015)... ... July 01, 2015 , ... During ... Posey (Manager, National Sales Training and Development) and Chuck Corso (Associate Sales Trainer) ... in Phoenix, AZ. LTEN brings together learning and development professionals from more than ...
(Date:7/1/2015)... ... ... Convoy of Hope will partner with local businesses, churches, government agencies ... at Spring Lake Park High School. , During the celebration, Convoy of Hope and ... and services including free food, health services, family portraits, job services, a carnival and ...
(Date:7/1/2015)... ... July 01, 2015 , ... Element Blue ™, a ... that it has received trademark protection for its SensorInsight® computer software platform. SensorInsight® ... from multiple sources providing an environment where users can view and compare real-time ...
(Date:7/1/2015)... Arizona (PRWEB) , ... July 01, 2015 , ... Amada ... opened a new office in the greater Phoenix area – their Mesa, Arizona ... move to senior care with their purchase of the rights to the area after ...
Breaking Medicine News(10 mins):Health News:Dr. Surya Challa of Chesapeake Vein Center and MedSpa Will be Featured on The Hampton Roads Show on WAVY-TV 2Health News:Dr. Surya Challa of Chesapeake Vein Center and MedSpa Will be Featured on The Hampton Roads Show on WAVY-TV 3Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 2Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 3Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 4Health News:Convoy of Hope Hosts Community Event in the Twin Cities 2Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 2Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 3Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 4Health News:Amada Senior Care Expands to Greater Phoenix Area 2
... has tried to analyze the many reasons why some teen ... with IVF treatments //. In his reading, they are just ... be ridiculed. ,Laurence Shaw, the deputy medical director ... the opinion that, it is the internal program charted by ...
... IT is a general occurrence that people living in ... than those who stay in the opposite //. ... and find a close link and scientific backing to ... societies with better hygiene have higher rates of allergy ...
... suggested by researchers that being exposed to too much ... chance of developing breast tumours //. Women particularly those ... considered to be of particularly risk. ,For ... Cancer Institute and National Institute of Environmental Health Sciences, ...
... a tool used to develop human disease research, now proved ... //complex virus - the vaccinia virus, which is used in ... for Allergy & Immunology (LIAI). ,Researchers at ... have used it to successfully predict immune response to one ...
... destroy viruses due to their protective protein cover which protects ... harmful //. ,Tackling this problem, scientists at the ... of the European Molecular Biology Laboratory (EMBL) in Grenoble have ... of a protein that allows the rabies virus to be ...
... in India open to acting in B'wood Sydney, Sabrina ... represent Australia in the Miss World contest, says she is ... of non-Australian parentage to win the Miss Australia title last ... a Lebanese father. ,Sabrina, who supports a charity ...
Cached Medicine News:Health News:Protected Environment v/s Unprotected Affect Hygiene Health Immunity 2Health News:Protected Environment v/s Unprotected Affect Hygiene Health Immunity 3Health News:Protected Environment v/s Unprotected Affect Hygiene Health Immunity 4Health News:Exposure To Artificial Light Could Be Cancerous 2Health News:Bioinformatics Made a Boon In Immune Response Study - LIAI Finds 2Health News:Bioinformatics Made a Boon In Immune Response Study - LIAI Finds 3
... extensive line of affordable, high-quality light guide ... light sources to provide optimal brightness during ... and durable design give you the flexibility ... efficiently. And each is fully-autoclavable so they ...
Used under fluoroscopy for initial location and positioning of the renal collecting system throughout a percutaneous nephrostomy. Supplied sterile in peel-open packages. Intended for one-time use....
The Linvatec 3mm and 5mm Universal Light Guides are autoclavable. They offer flexibility, superior light transmission, and universal fittings in a lightweight package....
ACMI™ offers an assortment of fiberoptic light guides, high transmission autoclavable fiberoptic light guides, and light guide adapters to connect our scopes to other manufacturers' light sourc...
Medicine Products: